Infectious Disease

Print
Loading...

Protecting the population from disease outbreaks

About

Building sound public health infectious disease control programs requires developing and implementing science-based policies, programs, and infrastructure for preventing infectious disease morbidity and mortality; control of outbreaks and vigilance against diminishing diseases; and prevention and response to reemerging and emerging infectious disease threats. Risk factors associated with such external drivers as globalization of commerce and transportation and climate change must also be taken into account.

At-Risk Populations

Some individuals are at increased risk of severe consequences during an influenza pandemic and may need special assistance to maintain basic medical care, as well as access to food and shelter. Project staff are currently working with health departments to refine and implement the planning recommendations.

Emerging Infectious Diseases

New infectious diseases continue to evolve and "emerge." ASTHO brings state and federal partners together to share surveillance information and develop and implement response plans.

H1N1 Flu Response

This new strain of the influenza virus is the latest emerging disease to pose a serious global threat

Healthcare-Associated Infections (HAI)

This project tracks state healthcare-associated infection laws and regulations, and promotes sound public policy to reduce the incidence of HAIs.

HIV/AIDS

ASTHO provides state-based public health input into the development of HIV/AIDS prevention policy on the issues of correctional health, substance abuse, HIV surveillance, injection drug use, and more.

Public Engagement Projects

ASTHO has been involved in planning and holding public engagement meetings on several important topics, including at-risk populations and healthcare-associated infections.

 

Staff

Caroline Barnhill, MPH, Director, Emerging Infections
Jim Blumenstock, MA, Public Health Practice
Anna DeBlois Buchanan, MPH, Senior Director, Immunization and Infectious Disease
Belinda Haerum, MPH, Analyst, Infectious Disease
Kathy Talkington, MPAff, Director, Immunization